BARBIERI, Elena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.209
EU - Europa 2.431
AS - Asia 2.135
SA - Sud America 324
Continente sconosciuto - Info sul continente non disponibili 69
AF - Africa 52
OC - Oceania 10
Totale 10.230
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.109
IT - Italia 626
SG - Singapore 623
CN - Cina 533
GB - Regno Unito 503
IE - Irlanda 346
HK - Hong Kong 263
BR - Brasile 238
SE - Svezia 217
VN - Vietnam 215
DE - Germania 214
BD - Bangladesh 153
FI - Finlandia 110
UA - Ucraina 106
RU - Federazione Russa 92
FR - Francia 66
IN - India 63
CA - Canada 60
TR - Turchia 51
KR - Corea 45
BG - Bulgaria 37
ID - Indonesia 35
AR - Argentina 24
NL - Olanda 21
IQ - Iraq 20
IR - Iran 18
ZA - Sudafrica 18
ES - Italia 15
JP - Giappone 15
MX - Messico 15
PL - Polonia 15
VE - Venezuela 15
AE - Emirati Arabi Uniti 12
CL - Cile 11
CO - Colombia 11
EC - Ecuador 11
MY - Malesia 11
PK - Pakistan 10
AZ - Azerbaigian 9
AU - Australia 8
TW - Taiwan 7
UZ - Uzbekistan 7
AT - Austria 6
BE - Belgio 6
EG - Egitto 6
JM - Giamaica 6
LT - Lituania 6
NG - Nigeria 6
PH - Filippine 6
PY - Paraguay 6
CZ - Repubblica Ceca 5
HN - Honduras 5
JO - Giordania 5
KE - Kenya 5
MT - Malta 5
NP - Nepal 5
TH - Thailandia 5
AL - Albania 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
MA - Marocco 4
PT - Portogallo 4
SA - Arabia Saudita 4
SI - Slovenia 4
UY - Uruguay 4
CH - Svizzera 3
DK - Danimarca 3
DZ - Algeria 3
EU - Europa 3
IL - Israele 3
LB - Libano 3
LV - Lettonia 3
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
EE - Estonia 2
ET - Etiopia 2
KG - Kirghizistan 2
NZ - Nuova Zelanda 2
OM - Oman 2
PA - Panama 2
PE - Perù 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
GA - Gabon 1
GD - Grenada 1
HU - Ungheria 1
KZ - Kazakistan 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
MN - Mongolia 1
Totale 10.158
Salva come PNG Salva come JPEG
Città #
Ashburn 530
Santa Clara 460
Singapore 423
Dublin 346
Fairfield 322
Southend 298
San Jose 294
Chandler 265
Hong Kong 258
Woodbridge 225
Houston 187
Jacksonville 176
Dearborn 168
Ann Arbor 162
Beijing 156
Chicago 141
Council Bluffs 141
Nyköping 131
Seattle 120
Wilmington 120
Los Angeles 108
Cambridge 107
London 88
New York 87
Hefei 82
Helsinki 79
The Dalles 70
Ho Chi Minh City 64
Dallas 57
Modena 57
Milan 48
Hanoi 46
Seoul 44
Munich 43
Rome 40
Salt Lake City 38
Columbus 37
Moscow 37
Princeton 37
Sofia 35
Buffalo 32
Eugene 32
Shanghai 31
Izmir 30
Lauterbourg 30
São Paulo 30
Jakarta 27
San Diego 26
Tampa 26
Elk Grove Village 25
Bremen 24
Orem 23
Bologna 22
Dong Ket 22
Phoenix 19
Fremont 16
Sterling 15
Atlanta 14
Lancaster 14
Naples 14
Redwood City 14
Catania 13
Boardman 12
Tokyo 12
Toronto 12
Frankfurt am Main 11
Haiphong 11
Palermo 11
Amsterdam 10
Florence 10
Turku 10
Da Nang 9
Denver 9
Newark 9
Norwalk 9
Poplar 9
Redondo Beach 9
Brasília 8
Montreal 8
Surrey 8
Verona 8
Brooklyn 7
Chennai 7
Des Moines 7
Dhaka 7
Falls Church 7
Miami 7
Rio de Janeiro 7
San Mateo 7
Tashkent 7
Warsaw 7
Baku 6
Bari 6
Belo Horizonte 6
Brescia 6
Cape Town 6
Detroit 6
Dulles 6
Ferrara 6
Johannesburg 6
Totale 6.935
Salva come PNG Salva come JPEG
Nome #
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVO 509
Comparison of HER-2 and hormone receptor expression in primary breast cancers and asynchronous paired metastases: impact on patient management 445
Magnetic Resonance Imaging and Ultrasonography in Predicting Infiltrating Residual Disease after Preoperative Chemotherapy in Stage II-III Breast Cancer 440
Use of Recombinant Factor IX and Thromboelastography in a Patient With Hemophilia B Undergoing Liver Transplantation: A Case Report 430
Predictors of human epidermal growth factor receptor 2 fluorescence in-situ hybridisation amplification in immunohistochemistry score 2+ infiltrating breast cancer: a single institution analysis. 401
Primary and secondary prevention to effectively reduce the risk of bisphosphonate-related osteonecrosis of the jaw in patients with bone metastases . 365
Anti-HER2 neoadjuvant and adjuvant therapies in HER2 positive breast cancer 362
Predictive and prognostic role of p53 according to tumor phenotype in breast cancer patients treated with preoperative chemotherapy: a single-institution analysis 361
Posterior reversible encephalopathy syndrome during ipilimumab therapy for malignant melanoma 352
Achievements and unmet needs in the management of advanced ovarian cancer 342
Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis 333
Ki67 as a Predictor of Response and Long Term Survival in Hormone Receptor Positive/HER2 Negative Breast Cancer Patients Treated with Preoperative Chemotherapy 330
Double-blind, placebo-controlled, multicentric randomized phase IIb neoadjuvant study of letrozole-lapatinib in postmenopausal HER2-negative, hormone receptor-positive operable breast cancer 329
Clinical-Pathological Characteristics of HER2+ Breast Cancers patients among BRCA1/2+ carriers tested in Modena Cancer Center. 327
Primary pulmonary cancer colliding with metastatic breast carcinoma: hitherto unreported cases of cancer-to-cancer metastasis focusing on clinical implications 314
Change in HER2 Status in HER2 Positive Operable Breast Cancer Patients Treated with Neoadjuvant Chemotherapy with or without Anti-HER2 Therapy: Analysis of Two Consecutive Cohorts 299
PREVALENCE OF NODE NEGATIVE AND SMALL SIZE TUMORS IN A NATIONAL, RANDOMISED, PHASE III ADJUVANT TRIAL IN HER2 + EARLY BREAST CANCER (SHORT-HER STUDY) 291
35. PREDICTORS OF HER2 FISH POSITIVITY IN PRIMARY BREAST CANCER DIAGNOSIS SCORED 2+ WITH IHC: RESULTS OF A SINGLE INSTITUTION ANALYSIS 287
Prognostic impact of estrogen receptor (ER) level changes during progression for patients with both ER-positive (ER+) primary breast cancer and paired recurrence 281
P53 EXPRESSION IS A SIGNIFICANT PREDICTOR OF RESPONSE AND PROGNOSIS IN STAGE II-III BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 271
Biomarkers predicting clinical benefit: fact or fiction? 269
Discordant HER2 Total and HER2 Homodimer Levels by HERmark Analysis in Matched Primary and Metastatic Breast Cancer FFPE Specimens. 258
COMPARISON OF HER-2 STATUS IN PRIMARY BREAST CANCER AND METASTATIC SITES: RESULTS FROM A SINGLE INSTITUTION ANALYSIS 256
Timing for starting second-line therapy in recurrent ovarian cancer 255
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 250
Tumori ginecologici 247
KI67 AS A PREDICTOR OF RESPONSE AND LONG TERM SURVIVAL IN HORMONE RECEPTOR POSITIVE/HER2 NEGATIVE BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY 247
ShortHER: TRATTAMENTO ADIUVANTE CON HERCEPTIN PER 3 MESI VERSO 12 MESI, IN ASSOCIAZIONE CON DUE DIFFERENTI REGIMI DI CHEMIOTERAPIA, NELLE PAZIENTI CON CARCINOMA MAMMARIO HER2 POSITIVE: ANALISI PRELIMINARE DELLE TOSSICITA’ 241
Prognostic role of HER2 loss after neoadjuvant therapy in patients with HER2-positive operable breast cancer 216
Adjuvant Endocrine Therapy in Premenopausal Women With Hormone Receptor-Positive Early-Stage Breast Cancer: Risk Stratification in a Real-World Setting 212
ACHIEVEMENTS AND UNMET NEEDS IN THE MANAGEMENT OF EPITHELIAL OVARIAN CANCER 210
Quantitative HER2 measurement and PI3K mutation profile in matched primary and metastatic breast cancer tissues. 197
VALUTAZIONE DEL RISCHIO DI TOSSICITA’ CARDIACA DI TRASTUZUMAB IN PAZIENTI AFFETTE DA CARCINOMA MAMMARIO IN TRATTAMENTO ADIUVANTE 190
PREDICTIVE AND PROGNOSTIC ROLE OF P53 EXPRESSION IN STAGE II-III BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY: A SINGLE INSTITUTION ANALYSIS 113
Totale 10.230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.519
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.519
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022387 0 0 0 12 11 23 27 13 64 45 121 71
2022/20231.047 97 98 58 76 71 103 13 62 403 11 29 26
2023/2024559 24 21 40 39 71 46 49 118 21 27 44 59
2024/20251.508 17 41 35 110 308 251 86 104 161 69 132 194
2025/20263.341 186 68 206 407 689 198 414 140 271 291 206 265
2026/2027670 104 193 220 153 0 0 0 0 0 0 0 0
Totale 10.230